‘So far, so good’ on leading COVID-19 vaccine

0
1

Britain’s AstraZeneca said on Thursday that good data was coming in so far on its vaccine for COVID-19, already in large-scale human trials and widely seen as the front-runner in the race for a shot against the novel coronavirus. The drugmaker, Britain’s most valuable listed company, also announced second quarter results that beat its sales and profit estimates, thanks to strong sales from a diverse product line-up.

NO COMMENTS